Genomic Amplification of UBQLN4 Is a Prognostic and Treatment Resistance Factor

Yuta Kobayashi, Matias A. Bustos, Yoshiaki Shoji, Ron D. Jachimowicz, Yosef Shiloh, Dave S.B. Hoon*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Fingerprint

Dive into the research topics of 'Genomic Amplification of UBQLN4 Is a Prognostic and Treatment Resistance Factor'. Together they form a unique fingerprint.

Keyphrases

Immunology and Microbiology

Pharmacology, Toxicology and Pharmaceutical Science